<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A crucial question in polyQ-induced <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> is the influence of <z:mp ids='MP_0002169'>wild type</z:mp> protein on the formation of aggregates and toxicity </plain></SENT>
<SENT sid="1" pm="."><plain>Recently it was shown that non-expanded ataxin-3 protein mitigated <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> in a Drosophila and mouse model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We now explored the effects of overexpressing non-expanded ataxin-3 with 15Q in a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> transgenic mouse model with 70 polyglutamine repeats </plain></SENT>
<SENT sid="3" pm="."><plain>These double-transgenic mice (dt) developed neurological symptoms with premature <z:hpo ids='HP_0011420'>death</z:hpo> at the age of 6 months comparable to the single-transgenic (st) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> <z:e sem="disease" ids="C0684309" disease_type="Experimental Model of Disease" abbrv="">disease model</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, immunohistochemistry revealed similar localization and distribution of nuclear aggregates in dt- and st-mutant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mice </plain></SENT>
<SENT sid="5" pm="."><plain>In a second dt-mutant mouse model, coexpression of ataxin-3 with 148Q attached to a nuclear export signal, which usually diminishes the phenotype, did even reinforce toxic effects of mutant expanded ataxin-3 </plain></SENT>
<SENT sid="6" pm="."><plain>We therefore conclude that overexpressing <z:mp ids='MP_0002169'>wild type</z:mp> ataxin-3 or mutant ataxin-3 with NES are not striking suppressors of polyglutamine-induced <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> and have thus no potential for future gene therapeutic interventions in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> </plain></SENT>
</text></document>